About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

POCARED Diagnostics, LTD, Field Study Protocol | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT01487148

POCARED Diagnostics, LTD, Field Study Protocol

This study is designed to compare the performance of the P-1000 System, POCARED's Rapid Diagnostic System which uses optical fluorescence analysis, to standard methods of uropathogen quantification an...

Lead sponsor: Pocared Diagnostics•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jonathan Gurfinkel

CONTACT

972-8-6999779 jonathan.gurfinkel@pocared.com

Sponsors

Lead Sponsor

Pocared Diagnostics

This study will be conducted at 5 sites, 4 in the United States and 1 site in Israel. 40,000 clinical specimens will be included and assessed by the laboratories using standard reference methods and the P-1000.

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Samples arriving in the laboratory for urine culture

Exclusion Criteria

•Samples \<=2mL
•Specimens stored at room temperature for more than 2 hours (unless a preservative is used)
•Specimens refrigerated for more than 24 hours
•Specimens requesting low count urine culture (\<100,000 CFU/mL \[colony forming units per milliliter\])
•Bloody specimens

Related studies

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

NCT06976125 · Urinary Tract Infections

RECRUITINGPhase 2

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT05488340 · Urinary Tract Infections

Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections

NCT07233473 · Urinary Tract Infections (UTIs)

RECRUITINGPhase 4

Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis

NCT07186465 · Cystitis, Recurrent, Urinary Tract Infections

RECRUITINGPhase 3

Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women

NCT07184827 · Recurrent Urinary Tract Infections in Women

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 7, 2011Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment40,000

Start dateDec 2011

Last updatedDec 7, 2011

Condition

Urinary Tract Infections

Locations shown

Southern California Permanente Medical Group (SCPMG) Regional Reference Laboratories

North Hollywood, California

Mayo Clinic

Rochester, Minnesota

Cleveland Clinic

Cleveland, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 7, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions